Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/02/27 11:22
2015/02/27 11:22
1d
Burt R. asks, "Can you talk about the impact of Breakthrough Therapy Designation on Celldex Therapeutics? I understand this is good news but less sure if it increases the chances for getting the...
2015/02/27 11:22
2015/02/27 11:22
Latest videos
2015/02/25 17:23
2015/02/25 17:23
3d
This strategy should sound familiar. GlaxoSmithKline (GSK:ADR) and Prosensa made essentially the same argument to explain away the negative results from the drisapersen phase III study in DMD patients...
2015/02/23 16:23
2015/02/23 16:23
5d
In January, Vertex said it was starting phase III studies of the VX-661/Kalydeco combination. Doesn't that lessen the significance of the phase IIb study we're waiting to see? Vertex's decision to...
2015/02/20 13:22
2015/02/20 13:22
8d
Sarissa, led by former Carl Icahn lieutenant Alex Denner, is Ariad's largest shareholder with a 6.9% stake in the biotech company. On Thursday, Sarissa informed Ariad that it is nominating two...
2015/02/06 11:22
2015/02/06 11:22
22d
There are so many moving parts to the hepatitis C story, it's really hard to track them all. You raise a very interesting and valid point. I agree, Merck's entry into the hepatitis C treatment market...
2015/02/04 19:29
2015/02/04 19:29
24d
Gilead, Drug Pricing Weigh Down Biotech, But Don't Get Scared Off With shares of Gilead Sciences falling in Wednesday trading after reporting better-than-expected earnings, TheStreet senior columnist...
2015/02/04 18:23
2015/02/04 18:23
24d
Hemispherx and its executives are defendants in a federal lawsuit filed by shareholders alleging the company made "material misrepresentations and omissions" about Ampligen and the FDA in 2012 in...
2015/01/30 15:23
2015/01/30 15:23
29d
CTI Biopharma is conducting two phase III studies of pacritinib in myelofibrosis. The first study -- the one we're discussing here -- is designed with a relatively low bar for success. Pacritinib is...
2015/02/27 11:22
2015/02/27 11:22
Latest from Twitter